TNF receptors in Kupffer cells

References

• Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992, 10, 411–452.
   PubMed Web of Science ®Google Scholar
• MacEwan DJ. TNF receptor subtype signalling: Differences and cellular consequences. Cell Signal 2002, 14, 477–492.
   PubMed Web of Science ®Google Scholar
• Carpentier I, Coornaert B, Beyaert R. Function and regulation of tumor necrosis factor receptor type 2. Curr Med Chem 2004, 11, 2205–2212.
   PubMed Web of Science ®Google Scholar
• Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003, 10, 45–65.
   PubMed Web of Science ®Google Scholar
• Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 2006, 12, 7413–7420.
   PubMed Web of Science ®Google Scholar
• Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990, 192, 245–261.
   PubMedGoogle Scholar
• Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996, 334, 246–254.
   PubMed Web of Science ®Google Scholar
• Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999, 20, 157–198.
   PubMed Web of Science ®Google Scholar
• Dasgupta P. Somatostatin analogues: Multiple roles in cellular proliferation, neoplasia, and angiogenesis. Pharmacol Ther 2004, 102, 61–85.
   PubMed Web of Science ®Google Scholar
• ten Bokum AM, Hofland LJ, van Hagen PM. Somatostatin and somatostatin receptors in the immune system: A review. Eur Cytokine Netw 2000, 11, 161–176.
   PubMed Web of Science ®Google Scholar
• Valatas V, Kolios G, Manousou P, Notas G, Xidakis C, Diamantis I, Kouroumalis E. Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br J Pharmacol 2004, 141, 477–487.
   PubMed Web of Science ®Google Scholar
• Valatas V, Kolios G, Manousou P, Xidakis C, Notas G, Ljumovic D, Kouroumalis EA. Secretion of inflammatory mediators by isolated rat Kupffer cells: The effect of octreotide. Regul Pept 2004, 120, 215–225.
   Google Scholar
• Xidakis C, Kolios G, Valatas V, Notas G, Mouzas I, Kouroumalis E. Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: A possible anti-tumour mechanism. Anticancer Res 2004, 24, 833–841.
   Google Scholar
• Xidakis C, Ljumovic D, Manousou P, Notas G, Valatas V, Kolios G, Kouroumalis E. Production of pro- and anti-fibrotic agents by rat Kupffer cells: The effect of octreotide. Dig Dis Sci 2005, 50, 935–941.
   PubMed Web of Science ®Google Scholar
• Valatas V, Xidakis C, Roumpaki H, Kolios G, Kouroumalis EA. Isolation of rat Kupffer cells: A combined methodology for highly purified primary cultures. Cell Biol Int 2003, 27, 67–73.
   Web of Science ®Google Scholar
• Knook DL, Sleyster EC. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 1976, 99, 444–449.
   PubMedGoogle Scholar
• Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON. Treatment of hepatocellular carcinoma with octreotide: A randomised controlled study. Gut 1998, 42, 442–447.
   PubMed Web of Science ®Google Scholar
• Barbare JC, Bouché O, Bonnetain F, Dahan L, Lombard-Bohas C, Faroux R, Raoul JL, Cattan S, Lemoine A, Blanc JF, Bronowicki JP, Zarski JP, Cazorla S, Gargot D, Thevenot T, Diaz E, Bastie A, Aparicio T, Bedenne L. Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study. Eur J Cancer 2009, 45, 1788–1797.
   Google Scholar
• Becker G, Allgaier HP, Olschewski M, Zähringer A, Blum HE; HECTOR Study Group. Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study. Hepatology 2007, 45, 9–15.
   PubMed Web of Science ®Google Scholar
• Yuen MF, Poon RT, Lai CL, Fan ST, Lo CM, Wong KW, Wong WM, Wong BC. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology 2002, 36, 687–691.
   PubMed Web of Science ®Google Scholar
• Samonakis DN, Notas G, Christodoulakis N, Kouroumalis EA. Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: A message not well taken. Dig Dis Sci 2008, 53, 2359–2365.
   PubMed Web of Science ®Google Scholar
• Pearson HJ, Anderson J, Chamberlain J, Bell PR. The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat. Cancer Immunol Immunother 1986, 23, 214–216.
   PubMedGoogle Scholar
• Heuff G, Oldenburg HS, Boutkan H, Visser JJ, Beelen RH, Van Rooijen N, Dijkstra CD, Meyer S. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 1993, 37, 125–130.
   Google Scholar
• Bayón LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996, 23, 1224–1231.
   PubMed Web of Science ®Google Scholar
• Timmers M, Vekemans K, Vermijlen D, Asosingh K, Kuppen P, Bouwens L, Wisse E, Braet F. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 2004, 112, 793–802.
   Google Scholar
• Timmers M, Vekemans K, Vermijlen D, Zanger RD, Wisse E, Braet F. Confocal laser scanning microscopic study of the killing of metastatic colon carcinoma cells by Kupffer cells in the early onset of hepatic metastasis. Comp Hepatol 2004, 3 Suppl 1, S50.
   Google Scholar
• Kan Z, Ivancev K, Lunderquist A, McCuskey PA, McCuskey RS, Wallace S. In vivo microscopy of hepatic metastases: Dynamic observation of tumor cell invasion and interaction with Kupffer cells. Hepatology 1995, 21, 487–494.
   Google Scholar
• Curley SA, Roh MS, Feig B, Oyedeji C, Kleinerman ES, Klostergaard J. Mechanisms of Kupffer cell cytotoxicity in vitro against the syngeneic murine colon adenocarcinoma line MCA26. J Leukoc Biol 1993, 53, 715–721.
   PubMed Web of Science ®Google Scholar
• Schuurman B, Heuff G, Beelen RH, Meyer S. Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon γ. Cancer Immunol Immunother 1994, 39, 179–184.
   Google Scholar
• Roh MS, Wang L, Oyedeji C, LeRoux ME, Curley SA, Pollock RE, Klostergaard J. Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery 1990, 108, 400–4; discussion 404.
   Google Scholar
• Saito H, Kurose I, Ebinuma H, Fukumura D, Higuchi H, Atsukawa K, Tada S, Kimura H, Yonei Y, Masuda T, Miura S, Ishii H. Kupffer cell-mediated cytotoxicity against hepatoma cells occurs through production of nitric oxide and adhesion via ICAM-1/CD18. Int Immunol 1996, 8, 1165–1172.
   Google Scholar
• Aono K, Isobe K, Nakashima I, Kondo S, Miyachi M, Nimura Y. Kupffer cells cytotoxicity against hepatoma cells is related to nitric oxide. Biochem Biophys Res Commun 1994, 201, 1175–1181.
   Google Scholar
• Fukumura D, Yonei Y, Kurose I, Saito H, Ohishi T, Higuchi H, Miura S, Kato S, Kimura H, Ebinuma H, Ishi H. Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo. Hepatology 1996, 24, 141–149.
   Google Scholar
• Kurose I, Saito H, Suematsu M, Fukumura D, Miura S, Morizane T, Tsuchiya M. Kupffer cell-mediated oxidative stress on colon cancer cell line visualized by digital imaging fluorescence microscopy. Cancer Lett 1991, 59, 201–209.
   PubMedGoogle Scholar
• Rushfeldt C, Sveinbjørnsson B, Seljelid R, Smedsrød B. Early events of hepatic metastasis formation in mice: Role of Kupffer and NK-cells in natural and interferon-γ-stimulated defense. J Surg Res 1999, 82, 209–215.
   PubMed Web of Science ®Google Scholar
• Lau WY, Chen GG, Lai PB, Chun YS, Leung BC, Chak EC, Lee JF, Chui AK. Induction of Fas and Fas ligand expression on malignant glioma cells by Kupffer cells, a potential pathway of antiliver metastases. J Surg Res 2001, 101, 44–51.
   Google Scholar
• Gangopadhyay A, Bajenova O, Kelly TM, Thomas P. Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: Implications for hepatic metastasis from colorectal cancer. Cancer Res 1996, 56, 4805–4810.
   Google Scholar
• Gangopadhyay A, Lazure DA, Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 1998, 16, 703–712.
   PubMed Web of Science ®Google Scholar
• Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 1997, 71, 612–619.
   PubMed Web of Science ®Google Scholar
• Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121, 977–990.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317, 121–124.
   PubMed Web of Science ®Google Scholar
• Engelmann H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 1990, 265, 1531–1536.
   PubMed Web of Science ®Google Scholar
• Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992, 175, 323–329.
   PubMed Web of Science ®Google Scholar
• Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000, 288, 2351–2354.
   PubMed Web of Science ®Google Scholar
• Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR. TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 2005, 19, 1637–1645.
   PubMed Web of Science ®Google Scholar
• Alexander-Miller MA, Derby MA, Sarin A, Henkart PA, Berzofsky JA. Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor α receptor II-mediated apoptosis of cytotoxic T lymphocytes. J Exp Med 1998, 188, 1391–1399.
   PubMed Web of Science ®Google Scholar
• Lin RH, Hwang YW, Yang BC, Lin CS. TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation. J Immunol 1997, 158, 598–603.
   Google Scholar
• Elzey BD, Griffith TS, Herndon JM, Barreiro R, Tschopp J, Ferguson TA. Regulation of Fas ligand-induced apoptosis by TNF. J Immunol 2001, 167, 3049–3056.
   PubMedGoogle Scholar
• Tsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol 2011, 17, 313–321.
   Google Scholar
• Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: Balancing life and death–A new approach to cancer therapy. J Clin Invest 2005, 115, 2625–2632.
   PubMed Web of Science ®Google Scholar